SCHEMBL29175994

SCHEMBL29175994

O=c1ccc2cc(Cl)ccc2[nH]c1=O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F11 P03951 1/20 0.67
▸ DAO P14920 2/20 0.61
▸ GRIN2D O15399 1/20 0.57
▸ GRIN3B O60391 1/20 0.57
▸ GRIN1 Q05586 1/20 0.57
▸ GRIN2A Q12879 1/20 0.57
▸ GRIN2B Q13224 1/20 0.57
▸ GRIN2C Q14957 1/20 0.57
▸ GRIN3A Q8TCU5 1/20 0.57
▸ F7 P08709 2/20 0.47
▸ F3 P13726 2/20 0.47
▸ LTA4H P09960 1/20 0.47
▸ AHR P35869 1/20 0.47
▸ NR4A2 P43354 1/20 0.47
▸ PARP1 P09874 1/20 0.46
▸ CDK5 Q00535 1/20 0.45
▸ CDK5R1 Q15078 1/20 0.45
▸ LOXL2 Q9Y4K0 1/20 0.44
▸ IDH1 O75874 2/20 0.43
▸ CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8872186 0.86 DAO (0.62) F11DAOGRIN2DGRIN3BGRIN1
SCHEMBL1052487 0.80 F11 (1.00) F11DAOGRIN2DGRIN3BGRIN1
SCHEMBL10140668 0.76 DAO (0.64) F11DAOGRIN2DGRIN3BGRIN1
SCHEMBL16767857 0.76 DAO (1.00) F11DAOGRIN2DGRIN3BGRIN1
SCHEMBL31143054 0.76 DAO (0.64) F11DAOGRIN2DGRIN3BGRIN1
SCHEMBL7882349 0.76 DAO (0.64) F11DAOGRIN2DGRIN3BGRIN1
SCHEMBL31378871 0.76 DAO (0.64) F11DAOGRIN2DGRIN3BGRIN1
SCHEMBL1367967 0.73 DAO (0.65) F11DAOGRIN2DGRIN3BGRIN1
SCHEMBL830009 0.73 DAO (0.60) F11DAOGRIN2DGRIN3BGRIN1
SCHEMBL22185938 0.73 DAO (0.60) F11DAOGRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117756717-A Tolvaptan intermediate and preparation method of tollvaptan 广州市桐晖药业有限公司 2024-03-26 — — CN disclosed
Send feedback